Drug Database
Back to search

Poland· PL-100537423

Diclovit

A acetic acid derivatives and related substances product containing produkt złożony, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.

ATC M01AB

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDiclovitATCM01ABREGISTER NO.PL-100537423PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about produkt złożonyAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Produkt złożony is registered in 2 of 19 countries.

Countries holding a registration under ATC M01AB (acetic acid derivatives and related substances), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose
Search produkt złożony products by name

Produkt złożony · ATC M01AB

2 / 19 countries

  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Produkt złożony
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
M01AB
ATC class
Acetic acid derivatives and related substances
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991599942
  • gtin
    05909991599959

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under M01AB

Acetic acid derivatives and related substances, as other registers publish it.

All produkt złożony products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/813757ad-3c46-4e5f-8ce7-29917501ee4e
GET /v1/drugs/813757ad-3c46-4e5f-8ce7-29917501ee4e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki dojelitowe, twarde",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909991599942 ¦ Rp ¦ 166892\n30 kaps.\n05909991599959 ¦ Rp ¦ 166893\n50 kaps.",
  "substance": "Diclofenacum natricum 50 mg + Thiamini hydrochloridum (vitaminum B1) 50 mg + Pyridoxini hydrochloridum (Vitaminum B6) 50 mg + Cyanocobalaminum 0.25 mg",
  "common_name": "Produkt złożony",
  "pl_product_id": "100537423",
  "pozwolenie_nr": "160/26",
  "auth_procedure": "IR",
  "authorisation_validity": "2031-04-28"
}
API referenceMCP serverPlans

See everything about produkt złożony.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console